ATE315380T1 - Epothilon zusammensetzungen - Google Patents

Epothilon zusammensetzungen

Info

Publication number
ATE315380T1
ATE315380T1 AT00949439T AT00949439T ATE315380T1 AT E315380 T1 ATE315380 T1 AT E315380T1 AT 00949439 T AT00949439 T AT 00949439T AT 00949439 T AT00949439 T AT 00949439T AT E315380 T1 ATE315380 T1 AT E315380T1
Authority
AT
Austria
Prior art keywords
epothilone
compositions
liposomal compositions
provides liposomal
provides
Prior art date
Application number
AT00949439T
Other languages
English (en)
Inventor
Jean-Claude Sonntag
Markus Wartmann
Karl-Heinz Altmann
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10858600&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE315380(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE315380T1 publication Critical patent/ATE315380T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
AT00949439T 1999-08-04 2000-08-02 Epothilon zusammensetzungen ATE315380T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9918429.3A GB9918429D0 (en) 1999-08-04 1999-08-04 Organic compounds

Publications (1)

Publication Number Publication Date
ATE315380T1 true ATE315380T1 (de) 2006-02-15

Family

ID=10858600

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00949439T ATE315380T1 (de) 1999-08-04 2000-08-02 Epothilon zusammensetzungen

Country Status (8)

Country Link
EP (1) EP1198225B1 (de)
AT (1) ATE315380T1 (de)
AU (1) AU6279500A (de)
DE (1) DE60025494T2 (de)
DK (1) DK1198225T3 (de)
ES (1) ES2254203T3 (de)
GB (1) GB9918429D0 (de)
WO (1) WO2001010412A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU756699B2 (en) 1996-12-03 2003-01-23 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US6589968B2 (en) 2001-02-13 2003-07-08 Kosan Biosciences, Inc. Epothilone compounds and methods for making and using the same
US6893859B2 (en) 2001-02-13 2005-05-17 Kosan Biosciences, Inc. Epothilone derivatives and methods for making and using the same
JP2005513167A (ja) * 2002-01-14 2005-05-12 ノバルティス アクチエンゲゼルシャフト エポシロン誘導体と代謝拮抗剤からなる組合せ
ATE439130T1 (de) * 2002-05-01 2009-08-15 Novartis Pharma Gmbh Epothilonderivat zur behandlung von hepatoma und anderen krebserkrankungen
DK2286795T3 (en) 2002-06-26 2017-02-06 Syncore Biotechnology Co Ltd PROCEDURE FOR PREPARING A Cationic LIPOSOMAL PREPARATION INCLUDING A LIPOPHIL COMPOUND
WO2004032923A1 (en) * 2002-10-11 2004-04-22 Dana-Farber Cancer Institute Inc Epothilone derivatives for the treatment of multiple myeloma
PT1562941E (pt) 2002-11-07 2010-01-25 Kosan Biosciences Inc Trans-9,10-desidroepotilona c e d, seus análogos e métodos de fabrico dos mesmos
US7691838B2 (en) 2003-05-30 2010-04-06 Kosan Biosciences Incorporated Method for treating diseases using HSP90-inhibiting agents in combination with antimitotics
AU2006242540A1 (en) 2005-04-29 2006-11-09 Kosan Biosciences Incorporated Method of treating multiple myeloma using 17-AAG of 17-AG of a prodrug of either
RU2011142620A (ru) * 2009-03-25 2013-04-27 Новартис Аг ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ ЛЕКАРСТВЕННОЕ СРЕДСТВО И киРНК
CA2799202C (en) 2010-05-18 2016-07-05 Cerulean Pharma Inc. Compositions and methods for treatment of autoimmune and other diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515016B2 (en) * 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis

Also Published As

Publication number Publication date
AU6279500A (en) 2001-03-05
DE60025494D1 (de) 2006-04-06
WO2001010412A1 (en) 2001-02-15
DE60025494T2 (de) 2006-07-27
ES2254203T3 (es) 2006-06-16
GB9918429D0 (en) 1999-10-06
EP1198225A1 (de) 2002-04-24
EP1198225B1 (de) 2006-01-11
DK1198225T3 (da) 2006-03-27

Similar Documents

Publication Publication Date Title
EA199900373A2 (ru) Фармацевтические композиции
DE60139185D1 (de) Vernetzbare perfluoroelastomarzusammensetzung
IT1308627B1 (it) Composizioni fluoroelastomeriche.
IT1308628B1 (it) Composizioni fluoroelastomeriche.
ATE376996T1 (de) Antibakterielle mittel
TR199802240T2 (de)
DE60022980D1 (de) Umgerührte Reibschweissverbindungen enthaltendes Bauelement
PT1473036E (pt) Solvato de hemitartarato de zolpidem
NO20023244D0 (no) Hydrogeler
DK1985626T3 (da) P. gingivalis-antigensammensætning
DK1198225T3 (da) Epothilonsammensætninger
SV2003000981A (es) Fenil-heterociclil-eteres ref. pcs10973
IT1320765B1 (it) Composizione di gomma.
DZ2815A1 (fr) Inhibiteurs de protéase.
ITTO20020744A1 (it) Composizione.
IT1307264B1 (it) Composizioni insetticide.
ITRE20010085A0 (it) Indumento intimo
IT1311356B1 (it) Disposizione di macchine.
ITMI20001951A0 (it) Amplificatore di corrente
ITTO20020745A1 (it) Composizione.
CY1110139T1 (el) Γλυκοπεπτιδικα αντιβιοτικα
CY1115144T1 (el) Παραγωγα του uk-2a
HN2000000084A (es) Inhibidores de metaloproteasa.
ES1048844Y (es) Cupon precinto desprendible de cajas de medicamentos.
IT1304174B1 (it) Composizioni perossidiche

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1198225

Country of ref document: EP